`571-272-7822
`
`
`
`
`
`Paper No. 4
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`SANOFI-AVENTIS U.S. LLC AND
`SANOFI-AVENTIS DEUTSCHLAND GMBH,
`Petitioners,
`
`v.
`
`ASTRAZENECA PHARMACUTICALS LP AND
`AMYLIN PHARMACEUTICALS, LLC,
`Patent Owners.
`____________
`
`Case IPR2016-00354
`Patent 8,445,647
`____________
`
`Mailed: December 29, 2015
`
`Before Alexander C. Levy, Trial Paralegal
`
`
`NOTICE OF FILING DATE ACCORDED TO PETITION
`AND
`TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE
`
`The petition for “inter partes review,” filed in the above proceeding
`has been accorded the filing date of December 16, 2015.
`
`
`
`Case IPR2016-00354
`Patent 8,445,647
`Patent Owner may file a preliminary response to the petition no later
`than three months from the date of this notice. The preliminary response is
`limited to setting forth the reasons why the requested review should not be
`instituted. Patent Owner may also file an election to waive the preliminary
`response to expedite the proceeding. For more information, please consult
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012),
`which is available on the Board Web site at http://www.uspto.gov/PTAB.
`Patent Owner is advised of the requirement to submit mandatory
`notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of
`the petition.
`The parties are encouraged to use the heading on the first page of this
`Notice for all future filings in the proceeding.
`The parties are advised that under 37 C.F.R. § 42.10(c), recognition of
`counsel pro hac vice requires a showing of good cause. The parties are
`authorized to file motions for pro hac vice admission under 37 C.F.R.
`§ 42.10(c). Such motions shall be filed in accordance with the “Order --
`Authorizing Motion for Pro Hac Vice Admission” in Case IPR2013-00639,
`Paper 7, a copy of which is available on the Board Web site under
`“Representative Orders, Decisions, and Notices.”
`The parties are reminded that unless otherwise permitted by 37 C.F.R.
`§ 42.6(b)(2), all filings in this proceeding must be made electronically in the
`Patent Review Processing System (PRPS), accessible from the Board Web
`site at http://www.uspto.gov/PTAB. To file documents, users must first
`obtain a user ID and password by registering with PRPS. Information
`regarding how to register with and use PRPS is available at the Board Web
`site.
`
`
`
`2
`
`
`
`Case IPR2016-00354
`Patent 8,445,647
`If there are any questions pertaining to this notice, please contact
`Alexander C. Levy at 571-272-0382 or the Patent Trial and Appeal Board at
`571-272-7822.
`
`
`PETITIONER:
`Paul H. Berghoff
`Joshua R. Rich
`Andrew W. Williams
`
`berghoff@mbhb.com
`rich@mbhb.com
`williams@mbhb.com
`
`PATENT OWNER:
`Mintz Levin /AstraZeneca AB
`One Financial Center
`Boston MA 02111
`
`JAMES F. VAUGHAN, ESQ.
`Womble Carlyle Sandridge & Rice, LLP
`Atlantic Station 271 17th Street, NW
`Suite 2400
`Atlanta, GA 30363-1017
`
`
`
`3
`
`